Clinical Pharmacokinetics and Pharmacodynamics of Antihyperglycemic Medications in Children and Adolescents with Type 2 Diabetes Mellitus
This article reviews the prevalence of obesity and T2DM in children and adolescents (youth). We then summarize published studies on safety and effectiveness of antihyperglycemic medications in youth. Drug disposition may be affected by age or puberty and thus the expression and activity of different pathways for drug metabolism and xenobiotic transporters are compared between youth and adults followed by a summary of pharmacokinetics studies of antihyperglycemic agents currently used in this population.
Source: Clinical Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research
More News: Actos | Avandia | Byetta | Children | Clinical Trials | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Drugs & Pharmacology | Eating Disorders & Weight Management | Endocrinology | Fatty Liver Disease (FLD) | Fortamet | Glimepiride | Glyburide | Insulin | Liver | Liver Disease | Metformin | Nutrition | Obesity | Sports Medicine | Study | Urology & Nephrology | Victoza